Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

BACKGROUND: Anti-angiogenic therapy with bevacizumab is the most widely used treatment option for recurrent glioblastoma, but therapeutic response varies substantially and effective biomarkers for patient selection are not available. To this end, we determine whether novel quantitative radiomic stra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Grossmann, Patrick, Narayan, Vivek, Chang, Ken, Rahman, Rifaquat, Abrey, Lauren, Reardon, David A, Schwartz, Lawrence H, Wen, Patrick Y, Alexander, Brian M, Huang, Raymond, Aerts, Hugo J W L
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Neuroimaging
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716072/
https://ncbi.nlm.nih.gov/pubmed/28499022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox092
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge